Pragma Bio: Funding, Investors & Team (Sep 2026)
Pragma Bio is a biotech firm that seeks to cure diseases such as cancer and autoimmune disorders by utilizing microbiome drugs. The company's proprietary practices in genome sequencing, synthetic biology, and AI assist in discovering biomarkers and treatments for difficult immunological disorders. By combining public and private data, the platform aggregates a microbiome database, allowing for better analytical processes that can help identify new biomarkers, predict clinical outcomes and increase statistical power. Pragma Bio was co-founded in 2018 in Millbrae, California, by Peter McCaffrey, Kovi Bessoff, Ayin Vala, and Kareem Barghouti.
Pragma Bio has raised $10.0M across 1 funding round on record, the most recent a Series A of $10.0M announced in Mar 2023.
That round is above the $5.8M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
Pragma Bio Company Profile and Key Stats
Latest funding round on record: Mar 2023.
Pragma Bio Funding Rounds
Pragma Bio Founders and Leadership Team
Contact details for the Pragma Bio team: 1 of 1 has an email address on file.
Start 14-day free trial →Pragma Bio Funding Compared to Other Artificial Intelligence Startups
Pragma Bio's latest round of $10.0M is above the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Pragma Bio in Artificial Intelligence and Millbrae
Companies Similar to Pragma Bio
Positron provides hardware for implementing Transformer Model Inference in generative AI systems. The…
Clay creates automation tools that improve data quality and streamline outreach efforts for sales and…
WINT - Water Intelligence developing advanced solutions for smart water management and control. The company…
KingsCrowd is an online private market rating and analytics platform for equity crowdfunding research and…
Cradlewise is an intelligent baby crib that learns from the baby's sleep patterns, spots the first signs of…
Capacity is an AI-powered helpdesk that automates support for customers and employees. Capacity connects…
AfterQuery is an artificial intelligence research and data platform focused on creating high-quality,…
The future of translation is conversational and Language I/O’s proprietary machine translation optimization…
Greptile is a platform driven by artificial intelligence that evaluates codebases and improves development…
Rhealth is a biotechnology company offering hospitals health management solutions utilizing advanced AI…
Pragma Bio Funding FAQs
What does Pragma Bio do?
Pragma Bio is a biotech firm that seeks to cure diseases such as cancer and autoimmune disorders by utilizing microbiome drugs. The company's proprietary practices in genome sequencing, synthetic biology, and AI assist in discovering biomarkers and treatments for difficult immunological disorders. By combining public and private data, the platform aggregates a microbiome database, allowing for better analytical processes that can help identify new biomarkers, predict clinical outcomes and increase statistical power. Pragma Bio was co-founded in 2018 in Millbrae, California, by Peter McCaffrey, Kovi Bessoff, Ayin Vala, and Kareem Barghouti.
How much funding has Pragma Bio raised?
Pragma Bio has raised $10.0M across 1 round on record. The most recent is a Series A of $10.0M announced in Mar 2023.
When did Pragma Bio last raise funding?
Pragma Bio's most recent funding round on record is a Series A of $10.0M, announced in Mar 2023.
Who founded Pragma Bio?
FundedIQ lists Ayin Vala (Founder) at Pragma Bio.
Where is Pragma Bio headquartered?
Pragma Bio is based in Millbrae, California, United States.
How many employees does Pragma Bio have?
Pragma Bio is in the 11-50 employee band.
How does Pragma Bio's funding compare to other Artificial Intelligence startups?
Pragma Bio's latest round of $10.0M is above the $5.8M median round size for Artificial Intelligence companies on FundedIQ across 7,234 tracked companies over the last two years.
About FundedIQ's Pragma Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Pragma Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.